Serum surfactant protein D as a biomarker for measuring lung involvement in obese patients with type 2 diabetes
…, X Muñoz, E Sanchez, A Seminario… - The Journal of …, 2017 - academic.oup.com
Context Lung impairment is a new target for late diabetic complications. Biomarkers that
could help identify patients requiring functional respiratory tests have not been reported. …
could help identify patients requiring functional respiratory tests have not been reported. …
[HTML][HTML] Prevalencia y características de la enfermedad pulmonar obstructiva crónica en no fumadores
Objetivo Conocer el perfil y las características de los enfermos diagnosticados de enfermedad
pulmonar obstructiva crónica (EPOC) y que nunca han sido fumadores. Diseño Estudio …
pulmonar obstructiva crónica (EPOC) y que nunca han sido fumadores. Diseño Estudio …
[HTML][HTML] Prognostic value of symptoms at lung cancer diagnosis: a three-year observational study
…, A Mas, S Bertran, G Fierro, A Seminario… - Journal of Thoracic …, 2021 - ncbi.nlm.nih.gov
Background Lung cancer is mainly diagnosed at advanced or locally advanced stages, usually
when symptoms become evident. However, sometimes it may be diagnosed incidentally …
when symptoms become evident. However, sometimes it may be diagnosed incidentally …
[HTML][HTML] Central sleep apnoea is related to the severity and short-term prognosis of acute coronary syndrome
…, A Aldoma, F Worner, E Galera, A Seminario… - PLoS …, 2016 - journals.plos.org
Objective To evaluate the relation of central sleep apnoea (CSA) to the severity and short-term
prognosis of patients who experience acute coronary syndrome (ACS). Methods …
prognosis of patients who experience acute coronary syndrome (ACS). Methods …
Study of the diagnostic delay of tuberculosis in Spain
A Seminario, L Anibarro, J Sabriá… - Archivos de …, 2021 - pubmed.ncbi.nlm.nih.gov
… Asunción Seminario …
[HTML][HTML] Correlation between tuberculin skin test and IGRAs with risk factors for the spread of infection in close contacts with sputum smear positive in pulmonary …
…, C Milà, J Solsona, MA Seminario… - BMC Infectious …, 2014 - Springer
Background The aim of the study was to assess the correlation between the tuberculin skin
test (TST) and in vitro interferon-gamma released assays (IGRAs) with risk factors for the …
test (TST) and in vitro interferon-gamma released assays (IGRAs) with risk factors for the …
Prevalence of chronic obstructive pulmonary disease (COPD) not diagnosed in a population with cardiovascular risk factors
J Montserrat-Capdevila, MA Seminario, P Godoy… - … Clínica (English Edition), 2018 - Elsevier
Background and objective The magnitude of undiagnosed COPD in our population with
cardiovascular risk factors (CVRF) is unknown. The objective of this study was to estimate the …
cardiovascular risk factors (CVRF) is unknown. The objective of this study was to estimate the …
Prevalence and characteristics of chronic obstructive pulmonary disease in non-smokers
… Seminario MA 7 , … Josep Montserrat-Capdevila, a, b, c, d, [low asterisk] Pere Godoy, b, c,
d, l Josep Ramon Marsal, e, f Marta Ortega, e, g Ferran Barbé, h, i, j Maria Teresa Castañ, b …
d, l Josep Ramon Marsal, e, f Marta Ortega, e, g Ferran Barbé, h, i, j Maria Teresa Castañ, b …
Estudio del retraso diagnóstico de la tuberculosis en España
MA Seminario, LA García, JS Mestres… - … : Organo oficial de la …, 2021 - dialnet.unirioja.es
Estudio del retraso diagnóstico de la tuberculosis en España - Dialnet Ayuda ¿En qué
podemos ayudarle? × Buscar en la ayuda Buscar Consultar la ayuda ¿En qué podemos …
podemos ayudarle? × Buscar en la ayuda Buscar Consultar la ayuda ¿En qué podemos …
Prevalencia de enfermedad pulmonar obstructiva crónica no diagnosticada en una población con factores de riesgo cardiovascular
J Montserrat-Capdevila, MA Seminario, P Godoy… - Medicina Clínica, 2018 - Elsevier
Antecedentes y objetivo Se desconoce cuál es la magnitud de la enfermedad pulmonar
obstructiva crónica (EPOC) no diagnosticada en nuestro medio en población con factores de …
obstructiva crónica (EPOC) no diagnosticada en nuestro medio en población con factores de …